Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

4 Jul 2008 16:15

RNS Number : 3949Y
Aberdeen Income & Growth VCT PLC
04 July 2008
Β 

ο»Ώ

AberdeenΒ Income and GrowthΒ VCT PLCΒ ("the Company")

Interim Management StatementΒ -Β Quarter ended 31 MayΒ 2008

ThisΒ Interim Management Statement,Β for theΒ quarterΒ endedΒ 31Β MayΒ 2008, is provided in accordance with Rule 4.3 of the Disclosure and TransparencyΒ Rules of the UK Listing AuthorityΒ andΒ also includes relevant informationΒ in respect of the period from 1Β JuneΒ 2008Β toΒ the date ofΒ issue.Β ThisΒ Statement has been prepared solely to provide additional informationΒ in orderΒ to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders,Β or any other party,Β for any other purpose.

FinancialΒ highlights

Net Asset Value* ("NAV") ofΒ 73.2pΒ per shareΒ atΒ 31 May 2008Β compared to 72.8p per share atΒ 29 February 2008.

Β 

FinalΒ dividendΒ ofΒ 2.3p per shareΒ to beΒ paidΒ onΒ 25Β JulyΒ 2008, bringing total dividend payment for the year ended 29 February 2008 to 5.8p, equivalent to a yield of 7.7% from an equity investment to a higher-rate taxpayer who subscribed at launch and, if the initial tax relief of 20% is taken into account, the effective annual yield rises to 9.7%. On the current mid-market price ofΒ 40.5p, the equivalent yield from an equity investment to a higher-rate taxpayer would beΒ 19.1%.

Β 

*The NAVΒ is unaudited andΒ reflects theΒ closingΒ bid priceΒ of quoted securitiesΒ atΒ 31Β MayΒ 2008. Unlisted companies areΒ normallyΒ valued on a six-monthly basis and the NAV incorporates the Directors'Β valuationΒ of unlistedΒ investmentsΒ asΒ atΒ 29 February 2008.Β 

InvestmentsΒ and Disposals

Β 

During the quarter endedΒ 31Β MayΒ 2008,Β investmentsΒ totallingΒ Β£1,008,000 were madeΒ inΒ threeΒ unlistedΒ and twoΒ AIM quoted companies.

Β 

DuringΒ theΒ same period, a combination of partial and complete disposals ofΒ sevenΒ AIM quoted investments generated aggregate proceeds of Β£257,000 against cost of Β£350,000 and included the sale of the holding in Citel Technologies where a loss of Β£165,000 was realised; however, the fall in the value of this investment had previously been recognised and there was no resulting impact on the Company's NAV. In addition,Β aΒ combination of partial and complete disposalsΒ ofΒ fiveΒ unlisted investments generated proceeds of Β£1,887,000 against cost of Β£1,283,000 with theΒ gain arising from the sale of PSCA InternationalΒ and having previously recognised in the NAV.

Β 

There were no other material transactions during the period under review.Β 

RecentΒ developmentsΒ 

Β 

BetweenΒ 31 May 2008Β and the date of this statement,Β investmentsΒ totallingΒ Β£798,000Β were made inΒ threeΒ unlistedΒ companiesΒ andΒ oneΒ AIM quotedΒ company.

Β 

DuringΒ the same post quarter-end period,Β disposalsΒ ofΒ oneΒ unlistedΒ investmentΒ andΒ eightΒ AIM quoted investmentsΒ generatedΒ aggregateΒ proceeds of Β£1,556,000Β against cost of Β£1,832,000. TheseΒ included theΒ disposal of a number of AIM quoted holdingsΒ where there was deemed to be little chance of a recovery in value andΒ whereΒ an aggregate realisedΒ ofΒ loss Β£776,000 had previously been recognised. Therefore,Β there wasΒ no resulting impact on the Company's NAVΒ and certain of these holdingsΒ were exchanged forΒ new sharesΒ inΒ an independent close-ended investment company that has been established to acquire quoted securities from financial institutions.Β Also includedΒ in the post quarter end disposals,Β was the sale of the unlisted investment in IΒ D Support Services Holdings whichΒ generated proceeds of Β£1,234,000Β against cost of Β£746,000Β and an investment of Β£89,000 in a new company, which is included in the figure quoted above, with the gain already having been recognised.

Other than described aboveΒ and changes inΒ theΒ value of investments quoted on regulated markets,Β theΒ Board is not aware of anyΒ material events during the period from 1Β MarchΒ toΒ 31Β MayΒ 2008,Β or in theΒ period from 1Β JuneΒ 2008Β to the date of this announcement, which would haveΒ hadΒ a material impact on the financial position of the Company.

Issued on behalf of the Board

Aberdeen Asset ManagementΒ PLC, Secretary

4Β July 2008

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUUUBUMUPRGAC
Date   Source Headline
26th Jun 20269:30 amRNSIssue of Equity
23rd Jun 20264:06 pmRNSAudited NAV - Dividend Investment Scheme
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.